Detalhe da pesquisa
1.
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Br J Haematol
; 198(5): 830-837, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35818641
2.
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
Semin Thromb Hemost
; 46(7): 807-814, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32882720
3.
Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
Biol Blood Marrow Transplant
; 23(1): 147-152, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27717872
4.
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
Br J Haematol
; 177(3): 441-448, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28197996
5.
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.
Eur J Haematol
; 107(4): 497-499, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34129711
6.
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry.
BMC Med Res Methodol
; 16(1): 151, 2016 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27829380
7.
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.
Lancet Oncol
; 14(11): 1129-1140, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24055414
8.
Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis.
Support Care Cancer
; 21(3): 841-6, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22972488
9.
Maori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Clin Lymphoma Myeloma Leuk
; 22(8): e762-e769, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35501256
10.
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR).
Bone Marrow Transplant
; 56(10): 2533-2543, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34011965
11.
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Clin Lymphoma Myeloma Leuk
; 21(6): e510-e520, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33785297
12.
The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemia.
Allergy Asthma Clin Immunol
; 15: 78, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31827542
13.
Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
Clin Lymphoma Myeloma Leuk
; 19(8): e415-e424, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31208889
14.
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.
Lancet Haematol
; 6(9): e459-e469, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31327687
15.
Distinctive features of polycythaemia vera in New Zealand Polynesians.
N Z Med J
; 131(1482): 38-45, 2018 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30235191
16.
Overnight transfusions in New Zealand hospitals: potential risk to patients.
N Z Med J
; 129(1431): 30-7, 2016 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27005871
17.
Maternal and perinatal predictors of newborn iron status.
N Z Med J
; 127(1402): 62-77, 2014 Sep 12.
Artigo
Inglês
| MEDLINE | ID: mdl-25228422
18.
PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.
Thromb Res
; 128(6): 577-82, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21621251
19.
The outcome of clinical parameters in adults with severe Type I Gaucher disease using very low dose enzyme replacement therapy.
Mol Genet Metab
; 92(1-2): 131-6, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17604204
20.
Laparoscopic splenectomy at Middlemore Hospital, New Zealand: a safe procedure with heterogeneous indications.
N Z Med J
; 119(1230): U1879, 2006 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-16532045